glp 1 pet scan GLP-1 Drug Use May Create New Challenges in Cancer Imaging GLP-1 agonists pose emerging challenge

From metabolism to mind: The expanding role of the GLP-1 receptor in neurotherapeutics

Common adverse effects of GLP-1 receptor agonists include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation) Injection site reactions Headache Fatigue Dizziness Important safety considerations include: Risk of hypoglycaemia when used with insulin or sulfonylureas (dose reduction of these agents may be needed) Potential worsening of diabetic retinopathy with semaglutide in patients with pre-existing retinopathy [18] Risk of dehydration and acute kidney injury from persistent vomiting or diarrhoea Pancreatitis, gallbladder disease, and potential thyroid C-cell tumours (observed in rodent studies, though human relevance remains uncertain) [19] [20] Patients should be counselled about persistent severe abdominal pain as a potential warning sign of pancreatitis requiring immediate medical attention

In many ways the recommendations align with what GLP-1 drug users report anyway that they have a new preference for fresh foods over processed foods (see PWC research below)

While these drugs are widely praised for helping people lose significant weight, the study found that physical activity did not increase alongside that weight lossas many might expect